A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

ICM Co. Ltd.

Status: Invitation-only

Conditions: Osteoarthritis, Knee

Treatments: Drug: Placebo; Genetic: ICM-203

Study type: Observational

Funder types: Industry

Identifiers

NCT05752032

ICM 20-1002

Details and patient eligibility

About

This is an observational study of the long term safety and efficacy of ICM-203.

Full description

Subjects who have received ICM-203 or matching placebo from ICM-203 clinical studies will be enrolled. Subjects will be contacted annually to collect safety and efficacy outcomes until 5 years after the last dose of ICM-203 or placebo.

Enrollment: 16 estimated patients

Sex: All

Ages: 50 to 80 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Previous receipt of ICM-203 or matching placebo

Exclusion criteria

• None

Trial design

16 participants in 2 patient groups

ICM-203

Description:

Participants who previously received ICM-203 in ICM-203 clinical studies

Treatment:

Genetic: ICM-203

Placebo

Description:

Participants who previously received placebo in ICM-203 clinical studies

Treatment:

Drug: Placebo